From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.

STIMULUS WHIPSAW

The S&P 500 ended down for the week with the Dow and Nasdaq slightly higher as the Street wrapped up early Thursday for the Christmas holiday. A stimulus package from Congress looked like it was going to emerge as a gift early in the week, but the president threw that plan into turmoil Wednesday when he demanded payments to Americans be jacked up from $600 to $2,000, a plan GOP House members officially derided Thursday. Still, the need for major economic relief became even more apparent in the data this week. Another 800,000 Americans joined the ranks of the unemployed last week. If the stimulus bill is not signed into law soon, federal unemployment benefits expire in a week, leaving millions of people without any income. Consumer spending dropped in November for the first time since the pandemic started, consumer confidence is at a four-month low, and even the resilient housing market is faltering with sales of new single-family homes dropping sharply in November. 

SHIPAGEDDON

The U.S. Postal Service is buckling under the weight of an absolute deluge of mail and package volume that is causing widespread delivery delays across the country. On-time performance was 86 percent last week, and perhaps even lower now. Foot traffic at retail stores was down 40 percent last weekend compared to last year. Everyone is doing their shopping online, and it has created a logjam that is cresting at the worst possible time. FedEx and UPS have instituted limits on their networks, leaving the USPS as the shipper of last resort. Best Buy is even experimenting with sending its own employees out to deliver items. As one meme going around puts it: "Stop trying to track that package. It's in God's hands now."

APPLE V. TESLA

Apple is reportedly jump-starting its plans to build a self-driving car from scratch. The iPhone maker is said to be targeting 2024 for the launch of an autonomous vehicle that will include a supposed breakthrough in battery technology. Apple's self-driving car strategy, codenamed Project Titan, has gone through fits and starts over the past several years, but the company is reinvigorating the project thanks to a "radical" new battery design. If those plans materialize, Apple would be going head-to-head with Tesla. CEO Elon Musk said this week that he had offered to sell Tesla to Apple three years ago as the company was faltering with the Model 3, but Apple boss Tim Cook "refused to take the meeting." Tesla shares closed the week down slightly after its first week as a member of the S&P 500.

FITNESS MERGER

Peloton closed at another all-time high this week after the fitness bike maker announced it was buying Precor, the commercial fitness equipment manufacturer, for $420 million. The deal gives Peloton access to 625,000 square feet of new manufacturing space in the U.S. that it desperately needs to keep up with the demand for its at-home products. Peloton will end 2020 as one of the top "stay-at-home" stocks of the pandemic, up an astonishing 470 percent on the year.

WALMART OPIOID LAWSUIT

Walmart will have to answer for its purported role in the opioid epidemic that has ravaged the U.S. The Justice Department filed suit against the superstore this week alleging that its pharmacies filled thousands of suspicious prescriptions that it "knew were invalid." Walmart already began fighting back, saying the DOJ's investigation has been "tainted by historical ethics violations." Walmart's stock dipped after the suit was announced.

Share:
More In Business
Stocks Close Mixed as Investors Process Earnings, Look Ahead to Thursday CPI
Stocks closed mixed Monday as a broader tech sell-off continued, leading the Nasdaq to close down 0.58%. Investors are keeping an eye on earnings, and also looking ahead to Thursday's CPI data, which will give an idea of how hot inflation could still be running. Steve Sosnick, Chief Strategist at Interactive Brokers, joins Closing Bell to discuss today's close, the Federal Reserve's plans to raise interest rates and taper asset purchasing, his 2022 market outlook, and more.
Chip Shortage Continues to Impact Automobile Production
The global chip shortage continues to weigh on the automotive industry. For example, Ford says it is suspending or cutting production at eight of its factories in North America through next week due to the shortage. Balu Balakrishnan, President and CEO of Power Integrations, joins Cheddar News' Closing Bell, where he elaborates on why the chip shortage has dragged into 2022.
Dan Ives: Apple is Likely 'Aggressively' Pursuing Peloton Takeover
Peloton has weathered a seemingly never-ending storm the past few months: PR blunders, sinking customer demand, and in recent weeks, reported cost-cutting and potential layoffs. Now, several companies are said to be in the mix as potential buyers: Amazon, Netflix, Disney, and Apple. How likely is it that one of these companies pursues a deal — and how likely is it that it will be Apple who buys Peloton? Dan Ives, Managing Director of Equity Research at Wedbush Securities, joins Closing Bell to discuss his thoughts about Apple pursuing a Peloton takeover,
Astra Scrubs NASA ELaNa 41 Space Launch, Sees Its Stock Fall
Astra aborted the launch for NASA ELaNa 41 Mission out of Cape Canaveral on Monday due to what was described as a minor issue, but the company's stock fell nearly 14 percent following the news. Jim Cantrell, CEO and co-founder of Phantom Space, which builds and launches spacecraft of its own, joined Cheddar to discuss the scrubbed mission. “The last thing you want is for this to go wrong, you're better to err on the side of safety expectations,” Cantrell explained, noting that the mission delay was a normal event.
TC BioPharm Goes Public, Looks to Future of Cancer, COVID-19 Cell Therapies
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
Load More